CYTOKINETICS INC — Director's Dealing 2021

Oct 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-10-19

Reporting Person: PARSHALL B LYNNE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-19	Common Stock	M	1999	$6.84	Acquired	6999	Direct
2021-10-19	Common Stock	S	1999	$35.7343	Disposed	5000	Direct
2021-10-19	Common Stock	M	8333	$6.6	Acquired	13333	Direct
2021-10-19	Common Stock	S	8333	$35.7343	Disposed	5000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-19	Non-Qualified Stock Option (right to buy)	$6.6	M	8333	Disposed	2023-02-07	Common Stock (8333)	Direct
2021-10-19	Non-Qualified Stock Option (right to buy)	$6.84	M	1999	Disposed	2023-04-01	Common Stock (1999)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021.